When you're trying to get the best performance out of Python, most developers immediately jump to complex algorithmic fixes, using C extensions, or obsessively running profiling tools. However, one of ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Generate: Biomedicines (Nasdaq: GENB), a clinical-stage generative biology ...